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Introduction
Technological advances and decreasing costs of DNA
sequencing have created a deluge of genomic data [1–3].
These include millions of genetic variants that require
interpretation relative to various traits or diseases. The
Variant Interpretation Community Of Special Interest
Group (VarI-COSI, formerly VarI-SIG) provides an
international forum for researchers to share progress in
their work to address the need for strategies to detect,
annotate and interpret variants in the context of health
and disease. The 8th edition of the VarI-COSI meeting
[4–9] was held on July 8th, 2018 at the ISMB meeting in
Chicago, Illinois (USA).
This year’s meeting of the VarI-COSI featured three
keynote talks, 11 research presentations and two indus-
try presentations describing new datasets, bioinformatic
methods, and scientific studies aimed at advancing our
understanding of genetic variation. In addition, we heard
presentations from our sponsors, Variantyx and Qiagen
describing technological developments for variant detec-
tion and prioritization.
This year, the VarI-COSI was divided into a morning
and afternoon session. The morning session began with
a keynote by Bonnie Berger describing the potential of
genomic crowdsourcing with privacy to significantly
boost data availability for genomic studies. Talks in this
session described approaches to mine position-specific
information from the genome to better annotate and
study genetic variation. Speakers described using infor-
mation about protein structure to study variants at pro-
tein interaction interfaces, identifying positions involved
in the functional tuning of proteins, using signatures of
purifying selection to implicate non-coding Mendelian
variants, and annotating variants with an expanded set
of conservation categories using machine learning.
The afternoon included two additional keynotes. Mona
Singh described work studying variation that affects pro-
tein interactions with target molecules to gain insights
into the pathogenesis of cancer. Olga Troyanskaya de-
scribed the application of deep learning to predict the ef-
fect of single nucleotide variants on the expression of
nearby genes. Talks in the afternoon session included
statistical developments to improve meta-analysis in
GWAS studies in the presence of heterogeneity, new
methods for detecting splicing and structural variants,
and different approaches using molecular measurements
or diverse phenotypes to gain improved insight into the
role of genetic variation in disease processes.
We welcome Antonio Rausell from the Institut Imagine,
Paris (France) to the VarICOSI organizing committee.
The VarI-COSI executive committee invites the com-
munity to provide feedback regarding meeting content
and format, as well as to participate in future sessions of
the meeting.
Manuscript submission and review
For this year’s VarI-COSI special issue received 12
manuscript submissions. All manuscripts were evaluated
by at least two reviewers, selected by a panel of three ed-
itors and 25 experts in the field (see Acknowledgements).
After 2 rounds of review 11 manuscripts were accepted
for publication. These presented novel strategies for im-
plicating biological functions underlying diverse human
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phenotypes [10], detecting new genes associated with
cardiovascular disease [11], inferring the impact of vari-
ants on protein stability [12], predicting the effects of
variants in membrane proteins [13], at post-translational
modification sites [14], on mRNA translation [15] and
on DNA ionization [16].
Other manuscripts describe the development methods
for improving variant calling [17] and analysis of struc-
tural variants [18] and studying the effects of somatic
mutations in cancer on metabolism [19] and tumor
interaction with the immune system [20].
The complete program of VarI-COSI meeting 2018
with presentation and poster abstracts is available at
http://varicosi.biofold.org/2018/schedu.html .
Further developments
We are working to organize the next VarI-COSI meeting
(ISMB/ECCB 2019; Basel, Switzerland; July 24th, 2019).
Further information about this coming meeting is available
on our website (http://varicosi.biofold.org/).
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